MDxHealth (MDXH) Equity Average (2022 - 2026)

MDxHealth has disclosed Equity Average across 5 years of filings, most recently posting -$16.2 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$16.2 million, down 255.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.2 million (down 255.33% YoY), and the FY2025 annual result was $4.5 billion, up 40686.0% from the prior year.
• Equity Average came in at -$16.2 million for Q1 2026 at MDxHealth, down from -$10.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $4.5 billion in Q2 2025 to a low of -$16.2 million in Q1 2026.
• The 5-year median for Equity Average is $12.5 million (2023), against an average of $698.6 million.
• Across the five-year window, Equity Average jumped 109857.68% in 2025 and tumbled 255.33% in 2026, its largest moves.
• MDxHealth's Equity Average stood at $15.4 million in 2022, then dropped by 18.64% to $12.5 million in 2023, then grew by 27.08% to $15.9 million in 2024, then plunged by 163.95% to -$10.2 million in 2025, then plunged by 58.78% to -$16.2 million in 2026.
• The last three Equity Average figures came in at -$16.2 million (Q1 2026), -$10.2 million (Q4 2025), and $4.5 billion (Q3 2025), per Business Quant data.